Health and Fitness

Two Diabetes Medications Don’t Slow Progression of Type 2 Diabetes in Youth

RISE Study
Dr. Kristen Nadeau, principal investigator of the RISE Pediatric Medication Study, discusses treatment with a RISE participant. (Children’s Hospital Colorado)

NIH-funded study adds to growing evidence that condition is more aggressive in youth.

Bethesda, Maryland—(ENEWSPF)—June 26, 2018
Contact: Amy F. Reiter

In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulinfollowed by the drug metformin, nor metformin alone preserved the body’s ability to make insulin, according…

Proud member of LION Publishers

Most read stories this week

Take a Survey

ARCHIVES